| The
achievement of AidooAid, an
enviable milestone in man's quest to grow hair back on receding
hairline, balding hair--and, alopecia generally, including premature
hair loss; is one which has propelled this great scientist, inventor,
pioneer and educator: Professor Frank Aidoo into the arena of world
recognition.
The following
are some of the many letters sent to doctors and scientist around
the world to introduce the achievement of AidooAid :
Letter
to FDA:
Aidoo
International Research & Marketing Inc.,
360 S.
Milliken Ave, Suite G, Ontario CA. 91761
Tel: (909)
605 7788 Fax: (909) 605 7789
David
Kessler, M.D. April 26, 1996
Commissioner:
Food & Drug Administration,
5600 Fishers
Lane,
Rockville,
MD 20857-001
Dear Dr.
Kessler,
Re: AidooAid
The Bald No More System.
This is
my second letter to you exactly two years todate; on the above
product--the end result of my 20 years of research work.
I am a
research scientist in the field of Enzymes and Alkaloids. My work
has led to the discovery of 35 virgin formats of enzymatic traits,
and 12 master alkaloids pre-emptors of invaluable accord to humankind...
In my
letter of April 22, 1994, I contested the ruling you made in January
1990 concerning Rogaine. The assertion was unequivocal in your
statement. It was that--and I quote: " Rogaine with 2% minoxidil
is the only product proven to stimulate hair growth." un quote.
The above
ruling is what led me to write you the letter referred to above;
of which I am enclosing a copy; and other scientific data collected
over the years legitimizing in total--the statement: AidooAid
The Bald No More System actually grows hair!...And that it grows
hair on sufferers of alopecia, including arieta, totalis and androgenetica.
(commonly known as male and female pattern baldness). And unlike
Rogaine, it has no side effects; and it grows hair on all areas
of the head -- not the vertex area alone, but also frontal and
what I call "annexal areas and patches."
I had
included the pictorial documentation to accent the uniqueness
of my work.
Your action
has led to a state within which my life’s work was deduced to
"semi-fraud" in the face of those who heard our claim that: AidooAid
actually grows hair!
In spite
of the fact that I sent you all this information, your department
was aware of this breakthrough sometime back in June 1992, in
which an article was written about my work in the Sun Telegraph
newspaper of San Bernardino, California; and an interview with
The Los Angeles Times.
Before
publication, your office was contacted and a statement relayed
to the above newspaper by your west coast bureau spokesperson:
Mike Shaffer, conceded to our validity, and yet, there was no
attempt on your part to redress or rescind your statement.
Rogaine
has been proven not to grow hair as ascribed by your office...
It is ineffective, and by that dimension, has destroyed the public’s
view and perception toward legitimate claims such as ours. It
cannot grow--and this is for refutation purposes: one hundred
th of hair AidooAid is capable of...
AidooAid does not stimulate hair
growth as asserted by Rogaine’s outlay... It actually re-activates
the dormant hair follicles to grow hair again!...And it does not
take 4 months or longer like Rogaine: ...The fact that it works
with the follicles, the re-activation becomes evident within two
to three weeks upon use, sometimes before! And being arranged
with an organic coenzs, the new hair does not fall "off" with
reduction or cessation of use. And therefore, unlike Rogaine,
it is not a lifelong proposition...You have all this, including
all the pertinent scientific data on your record!
My work
has revealed that there is an unnatural membrane which I call:
gHanape-bio. It grows to hinder--restricting the "free flow" of
sebumatic factors to the follicles. Once the gHanape-bio is debased,
the follicle(s) assume accord of viability--growing hair again
into its anagenic state.
I love
America, and I want America to benefit from my findings and discoveries.
And as a scientist, there have been times when I have thought
of selling my work to other nations and pharmaceutical companies...
In essence, offer them the leadership in this arena.
I need
to be accorded a reply to this my second letter; to which copies
are also sent to the names enumerated below.
Sincerely,
Frank
Aidoo. Ph.D
Enzyme
& Alkaloids Research Scientist
cc. News
Editor CNN cc. Editor: New York Times
cc. Editor:
Washington Post cc. American Academy of Dermatology
cc. Governor
Pete Wilson. cc. Mike Shaffer, West Coast office FDA

OCT 21 1997
Frank Aidoo Ph.D,
601 S. Milliken Avenue Suite P Ontario,
California 91761
Dear Dr. Aidoo:
This is in response to your letter of July 27, 1997,
to Senator John McCain regarding your product AidooAid. Senator
McCain requested that we respond directly to you.
According to your letter, two previous letters you
sent the Food and Drug Administration (FDA or the Agency) were
not answered. We want you to know that the Agency has no record
of having received these letters, and we are sorry for the frustration
you have experienced in not receiving answers.
From the information provided in your letter, we
believe your product has the potential to be considered a drug
under the provisions of sections 201(g) and 201(p) of the Federal
Food, Drug, and Cosmetic (FDC) Act (pertinent sections enclosed)
which define what is considered a drug under the law. Also enclosed
is a copy of section 310.527 of Title 21 of the Code of Federal
Regulations (CFR). This section provides information on products
for hair growth or hair loss prevention
FDA regulates the manufacture, sale, and distribution
of drugs in the United States under the authority of the FDC Act,
and reviews the data included in New Drug Applications (NDAs)
that are submitted for approval. Enclosed is a copy of an FDA
consumer special report entitled "From Test Tube to Patient: New
Drug Development in the United States." This report will provide
a general overview of the drug development process. After reading
this report, you may wish to refer to the FDC Act and Title 21,
CFR from the Government Printing Office (GPO). These references
contain information such as regulatory definitions and the data
needed to support an approval of an NDA and marketing regulations
(there will be a charge for these manuals). Title 21, CFR is available
through our website at: www.fda.gov/cder. Select the "Regulatory
Guidance" icon, then select "Title 21, Code of Federal Regulations."
You may also wish to visit your local library and consult these
references. Finally, you can purchase copies through GPO. The
GPO can be reached at the following phone number and address:
The Government Printing Office Superintendent of
Documents
Attention: New Orders
P.O. Box 371954 Pittsburgh,
Pennsylvania 15250-7954
Phone: (202) 512-1800 Fax: (202) 512-2250
If you decide to pursue the development of these
products, you can contact the Drug Information Branch and request
an Investigational New Drug (IND) package. The Drug Information
office can provide information on any organizations, grants, or
other agencies that assist small drug businesses. If you wish
to contact them, they can be reached at the following phone number
and address:
Food and Drug Information (HFD-210) 5600 Fishers
Lane
Rockville, Maryland 20857
Phone: (301) 827-4573
For information on user fees, please contact the
Office of External Affairs, Industry Liaison Staff at (301) 827-3430.
They can send you a package that contains all of the current information
on user fees. Please note that small businesses can apply for
a user fee exemption.
We hope this information is helpful.
Sincerely Diane E. Thompson
Associate Commissioner for Legislative Affairs
3 Enclosures Section 201 FDC Act 21 CFR section
310.527 FDA Consumer,
"From Test Tube to Patient
July 27, 1997
Senator John McCain,
Chairman U.S. Committee on Commerce,
Science & Transportation.
Washington DC.
Dear Senator,
AidooAid
A Scientific Breakthrough
As per my e-mail of July 27, 1997, I hereby enclose the pertinent
documents I advised will be sent under a separate cover.
I take this moment to thank you in advance for the speedy attention
offered to my e-mails. Again, thank you.
Sir, as the attached letter (copy) sent to the then Commissioner
of FDA Dr. David Kessler will show, I am a research scientist
in the field of Enzyme and Alkaloid. My work has lead to
the discovery of 35 newly formatted Enzymes; and 12 Virgin Alkaloids
of unparalleled importance within the medium of science.
I have unraveled and utilized the virtues coherent within one
Enzymatic base--and supported it with an adjunct (co-enzyme) in
an empirical scientific arrangement to achieve a breakthrough
in the "re-activation" of the dormant hair follicles
to GROW HAIR again! ...Being that this order of achievement is
organic in it's accentuation, it grows hair on all types of hair,
and does not produce any side effects.
...Within some of my other prevailing base(s) of Enzymes and
Alkaloids--all being proprietary with legible style of conduction,
there exist discoveries bearing composers of other biological
effusers capable of suppressing and normalizing--in some cases:
"idiopathic" human abnormalities and diseases.
Over 5 years ago, a local newspaper hearing of my work sent a
team to cover it. (Sun Telegraph of San Bernardino, California).
Being that the FDA had asserted there was nothing but Rogaine--a
product serendipitously discovered, and fundamentally a Drug for
the controlling of hypertension--and marked as a topical "hair
growing" product, I requested the Commissioner to rescind
his words; or investigate my claim. I have spent over 20
years in this field of research--collecting data pictorially;
and studying the different forms of alopecia left to conjecture
within the scientific community...of which I have tonated usable
terminology for their identification.
I submitted my work to AMA and over 1000 physicians in the field
of dermatology; including notable medical schools; and have been
shunned due to the statement made by the then commissioner in
1991 concerning Rogaine.
On two consecutive times, I wrote Dr. Kessler providing him with
all the necessary information for revision; with no acknowledgement
or reply resulting...
Sir, I believe that America being the world leader within the
field of science can only hold on to it's leadership when people
like myself are accorded due recognition and equity--even in science;
especially, when I hold the secret to this phenomenon...including
others yet to be revealed.
My request is based on the fundamental truth--which we all seek
for: especially when a statement is antithesis to the prevailing
in science. Sir, I have provided all the pre-requisite needed
for revisiting the Commissioner's statement; and have also written
to Governor Pete Wilson of California--as I reside in his state
(copy attached).
I have since then received an unceremonious visit by an individual
who announced himself as an FTC agent, who, after seeing the postings
of documents and pictures of "before and after" of some
users in my office, has failed to "officially" announce
his findings.
Sir, I wish and request that your office and chair investigate
what I have brought before you. In a country where innovation
and creativeness are encouraged, I can only site a scenario of
inadvertency on Dr. Kessler's part; because, by all account--notwithstanding
the scientific and pictorial submitted, the statement made in
his capacity, clearly, legitimized Rogaine with monopolistic stripes:
an official rubber stamp--in essence, in an industry where they
have not been able to show any "scientific-pictorial"
proof:; especially, when the statement was with all accord of
conviction and honesty of an FDA Commissioner.. Unfortunately,
the said product (Rogaine) has since failed to live up to it's
relish: Based on what I have submitted, and by virtue of the fact
that my work has global connotation and meaning, that, I be accorded
an investigation into my citation...
I am yours sincerely,
Frank Aidoo Ph.D.
*Sir, my work is posted on the internet--with the world wide
address:
www.aidooaid.com
This information and other may be accessed; and are for your
perusal...
cc: Committee Members
Senators:
|
Ted Stevens, Alaska
Conrad Burns, Montana
Slade Gortan, Washington
Trent Lott, Mississippi
Kay Bailey Hutchison, Texas
Olympia J. Snowe, Maine
John Ashcroft, Missouri
William Frist, Tennessee
Spencer Abraham, Michigan
Sam Brownback, Kansas
|
Senators:
|
Ersnest F. Hollings, South Carolina
Daniel K. Inouye, Hawaii
Wendell H. Ford, Kentucky
John D. Rockefeller IV, West Virginia
John F. Kerry, Massachusetts
John B. Breaux, Louisiana
Richard H. Bryan, Nevada
Byron L. Dorgan, North Dakota
Ron Wyden, Oregon |
Enc:
COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION
WASHINGTON, DC 20510-6125
August 18, 1997
Mr. Frank Aidoo
Aidoo International 601 S. Milliken Ave.,
Suite P Ontario, CA 91761
Dear Mr. Aidoo:
Thank you for your letter regarding Aidoo Aid and the enzyme and
alkaloid research that you have been conducting. I am always glad
to have the opportunity to be of assistance
I have contacted the Associate Commissioner for Health Affairs
at the Food and Drug Administration about the difficulty that
you have encountered with Aidoo on your behalf. I have asked for
a prompt response to be sent directly to you.
Please do not hesitate to contact me if you have any further questions
or comments.
Sincerely,

John McCain
Chairman
JM/bm
Diane E. Thompson,
Associate Commissioner for Legislative Affairs,
U.S. Food
& Drug Administration,
Rockville,
MD 20857
Dear
Ms. Thompson,
Re:
AidooAid
I have received your letter of October 21, 1997, in answer to
one on my behalf from Senator John McCain: the chairman of the
U.S. Committee on Commerce, Science and Transportation. I was taken “aback” by inference that you did not receive
my letter sent to the department—addressed to the former commissioner
Dr. David Kessler.
To establish the viability of my letter, I enclose herewith
the “return receipt” of delivery from the U.S. Postal Service.
In reading your response, I notice the “theme” of my letter—the
contention and the essence of it—being the statement made by the
then commissioner that Rogaine is the only product proven to grow
hair was not addressed.
As I commented, the statement was emphatical, very conclusive.
It appeared to have represented the totality of scientific motion,
and as such resonated across the GLOBE—measuring with his stand
as the Commissioner of Unite States Food & Drug Administration
(FDA).
Ms. Thompson, the fact of the matter is: my 12 year old son and
his classmates cannot understand why they clearly see in accord
’hair’ on PEOPLE WHO DID NOT HAVE HAIR, (after examining pictures/data
of users of AidooAid and meeting some…) but are in essence
accosted to disregard the prevailing, and are to adopt
words of a trusted keeper of United States government—totally
inconsistent—and at odd with what they clearly see with their
reasoning: It demarcates their understanding; and are left
confused and frustrated!
--Pertaining to classification of products, my research which
covered more than 20 years, also measured the categories under
which “cosmetics and natural based” products are augmented under
the laws of the United States as enumerated under the FDA guidelines.(By
your suggestion, I have re-visited them thoroughly—concentrating
on the define of “herbal,” as the base of my work fits more under
this category.)
AidooAid is a “scientific breakthrough” that uses a NON-DRUG
base! And are unlike “drug” based products such as Minoxidel (Rogaine
by Upjohn), and Finasteride (Merck’s Proscar), a drug awaiting
your conferation.
Science, I believe, and trust you will agree is still evolving.
It does not have answer(s) to all our ill(s) and will never.
Your inversion that it is only “drug” that has the ability to
grow hair has no bases; and by the data and support I have collected
to date deems that adage to be totally false. My work therefore,
has made such theory held before the emergence of AidooAid obsolete,
since the “proof and evidence” presented cannot be refuted.
At this state, I request as a matter of scientific fact, that,
a statement be made to the effect that AidooAid has the ability
to re-activate the “dormant hair follicle” to grow hair again…and
more so that Rogaine or Finasteride; and without any of the side
effects; being that it utilizes “a breakthrough” catelization
of enzymatic order, to which the data and pictorial submitted
to date suffice…
As I stated in my letter to the Senator—in his esteem capacity,
I believe this great NATION called America epitomizes progress
and truth; and I also believe your department was requested to
answer my citation. This warrants clarification in view
of the fact that AidooAid grows hair…and achieves an unprecedented
result, far capable than any product out in the market (being
those bearing activance of Drug, OTC, Homeopathic or botanical/herbal
preparation).
As you may have seen the pictorial data
presented on our internet site, AidooAid grows hair on sufferers
of male and female pattern baldness (Androgenic Alopecia).
It stops hair loss; and unlike the others, it works well
on both frontal and vertex hair loss; and being that the base is
organic in composition, when a user discontinue its use after he/she
has grown their hair back, the hair does not fall out! …This is
achieved because of the fact that it is not a drug like Minoxidel
or Finasteride where cessation of use denotes resumption of hair
loss…and is meant therefore to be used indefinitely.
–They are drugs! —And as such unnaturally cajoles/stimulates
growth: usually “vellus” hair growth, while AidooAid facilitates
the “dormant hair follicle” to use its own chemistry to grow hair
back naturally—resulting in the pictorial and data posted: one that
cannot be duplicated using any DRUG-BASED PRODUCT.
I have posted documents detailing my work including over one hundred
pictorial data substantiation its efficacy. It should also be conferred
that my work is a BREAKTHROUGH IN THIS FIELD OF SCIENTIFIC RESEARCH
and REASONING, and for the sake of human progress should be embraced.
As an empiricist, it would be appropriate to understand that my
theory and its format are markedly antithesis to the prevailing,
as it further enhances man’s ability to redress some of the “idiopathic”
complexities from a different angle: such as the one used in achieving
the results I have presented including others yet to be revealed…
I look forward to your certain reply.
Frank
Aidoo Ph.D
cc:
Senator John McCain

January 5, 1998
Frank Aidoo, Ph.D.
Aidoo Internation Research & Marketing, Inc.
601 S. Milliken Avenue, Suite P
Ontario, CA 91761
Dear Dr. Aidoo:
I am responding to your November 17, 1997, letter
to Diane Thompson at the Food and Drug Administration regarding
your product AidooAid. Your letter has been referred to the Center
for Drug Evaluation and Research for a reply.
As stated in Ms. Thompson's October 21, 1997, letter
to you, we consider your product to be a drug under the provisions
of section 201(g) and 201(p) of the Federal Food, Drug, and Cosmetic
Act, therefore the product may not be legally marketed unless
the product has an approved New Drug application (NDA). Further,
regulation coveing hair growht products in Part 310.527(b) (copy
enclosed) of Title 21 of the Code of Federal Regualations (21
CFR) state:
"(b) Any OTC drug product that is labeled,
represented , or promoted for external use as a hair grower or
for hiar loss prevention is regareded as a new drugh within the
meaning of section 201(p) of the Federal Food, Drug, and Cosmetic
Act (the act), for which an approved new drug application under
section 505 of the act and part 314 of this chapter is required
for marketing. In the absence of an approved new drug application,
such product is also misbranded under section 502 of the act."
We are sending, under separate cover, the document
and forms for filing an NDA. The NDA must contain adequate data,
including clinical trials, which establish that the drugs is safe
and effective for the intended use. This is the process of proving
that your product is effective, which has been the focus of your
letter. The regualtions covering the NDA process are found in
21 CFR 312 and 314. The agency will be more that willing to review
your new drug application and clinical data supporting claims
of safety and efficacy for the AidooAid product. Once a completed
new drug application is received we can begin the review process
of your product. If you need additional guidance documents pertaining
to submission of a new drug application please request them from
our Drug Information Branch at 301-594-4573.
Sincerely yours,
Celia A. DeLawter
Executive Secretartiat (HFD-6)
Center for Drug Evaluation and Research
Letter
to Doctors:
Aidoo
International Research & Marketing Inc.,
360 S.
Milliken Ave, Suite G,Ontario, CA. 92761.
Tel: (909)
605 7788 Fax: (909) 605 7789.
Dear Dr.
Re: AidooAid
The Bald No More System.
This letter
is to introduce you to a "new" discovery -- an all natural base
of Enzyme and Alkaloids with the ability to "re-activate" the
dormant hair follicles to grow hair again.
A breakthrough
discovery by Frank Aidoo. Ph.D., a Research Scientist in the field
of Enzyme and Alkaloids. ...An empirical work spanning over 20
years in isolation and circumscription has led to this find: an
organic catalyst of an enzymatic order -- punctuated with co-enzymes
of "newly" discovered alkaloidic property to re-activating the
"dormant hair follicles" to grow hair again into its anagenic
state.
The result,
therefore, is a product that elicits growth (of hair) on sufferers
of: Alopecia: (arieta, totalis or androgenic).
Arranged
under a newly isolate vertex of covalency, it provides all the
natural composites; including proteinic virtues to build triapite
sebumatic factors to yield growth.
...Compounded
with natural composites, there are fewer denaturing within the
base; resulting therefore, in a predictable hair growth in 99.9%
of cases of those who suffer with arieta, totalis and infantal
androgenetica. Unlike Rogaine -- composite of minoxidil; AidooAid
The Bald No More System elicit vertex and frontal (receding hairline)
growth; including q/marks and annexial patches.
It also
has no side effects; and being biologically semblance to the requisite
of the follicle’s traits, once the individual has achieved the
result needed, he/she could switch to our Phase2 formula: the
maintenance kit.
Using
AidooAid, therefore, is not a life
long proposition. The new hair also remains with all the attributes
of anagency...as nature then recur itself!
This product
has gone through all rigor: and is marketed unequivocally as "hair
growing product." It is also a breakthrough known to the FDA,
including other agencies.
We are
enclosing herewith: other scientific documentation (in the form
of pictures of: before and after of some users). You will also
notice there has been some news coverage (investigative) by some
respectable newspapers here in California. We enclose also price
list, and a poster for your office.
Thank
you.
Harold
"HK" Kennedy,
Physicians
Marketing Director.
HK/cc
***enc.
|